Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF Receive the the latest news, research, and presentations from major meetings right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results